Suggested remit: To appraise the clinical and cost effectiveness of icosapent ethyl within its marketing authorisation for preventing cardiovascular events due to elevated triglycerides.
Status
|
In progress
|
Decision
|
Selected
|
Process |
STA 2018
|
ID number |
3831
|
Provisional Schedule
Expected publication |
20 July 2022 |
Project Team
Project lead |
Louise Jafferally |
Email enquiries
External Assessment Group |
Kleijnen Systematic Reviews Ltd |
Stakeholders
Companies sponsors |
Amarin Corporation (Icosapent ethyl) |
Others |
Department for Health and Social Care |
|
NHS England |
|
Welsh Government |
Patient carer groups |
HEART UK |
Professional groups |
Association of British Clinical Diabetologists |
|
British Cardiovascular Society |
|
Royal College of Physicians |
Associated guideline groups |
National Guideline Alliance |
Associated public health groups |
None |
Comparator companies |
None |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
British National Formulary |
|
Department of Health, Social Services and Public Safety for Northern Ireland |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare products Regulatory Agency |
|
Scottish Medicines Consortium |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
Cochrane Heart Group |
Date
|
Update
|
04 May 2022
|
Committee meeting: 3 |
28 March 2022 - 19 April 2022
|
Draft guidance: 2 |
08 March 2022
|
Committee meeting: 2 |
01 February 2022 - 22 February 2022
|
Draft guidance |
11 January 2022
|
Committee meeting: 1 |
24 May 2021
|
The Department for Health and Social Care has asked NICE to conduct an appraisal of icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in adults with elevated triglycerides. Following on from a request received from the company, the timelines for this appraisal have been revised in order to facilitate a comprehensive and robust submission. |
15 February 2021
|
Invitation to participate |
15 February 2021
|
In progress. In progress. |
25 September 2020 - 23 October 2020
|
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators |
For further information on our processes and methods, please see our CHTE processes and methods manual